SCHEDULE: Macquarie Discloses 5.06% Stake in AtriCure Inc.

Macquarie Group Limited and its affiliates have reported a 5.06% beneficial ownership stake in AtriCure Inc., totaling 2,503,205 common shares.

Summary

• Macquarie Group Limited, along with its subsidiaries Macquarie Management Holdings Inc. and Macquarie Investment Management Business Trust, has jointly filed a Schedule 13G.
• The filing reports beneficial ownership of 2,503,205 common shares of AtriCure Inc.
• This aggregate amount represents 5.06% of AtriCure Inc.'s common shares outstanding.
• Macquarie Management Holdings Inc. and Macquarie Investment Management Business Trust each hold sole voting and sole dispositive power over all 2,503,205 shares.
• Macquarie Group Limited, as the parent holding company, reports no sole or shared voting or dispositive power directly over these shares.
• The securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of AtriCure Inc.

Sentiment

Score: 5

Explanation: The filing is a factual disclosure of beneficial ownership and does not contain information that would inherently indicate positive or negative sentiment regarding the company's performance or outlook.

Future Outlook

NA

Industry Context

This filing indicates a significant institutional investment by Macquarie Group, a global financial services firm, in AtriCure Inc., a company in the medical device sector. Such disclosures are standard for large institutional holdings and provide transparency regarding major shareholders, signaling institutional interest in the company.

Stakeholder Impact

• Provides transparency to shareholders regarding significant institutional ownership.
• May signal institutional confidence in AtriCure Inc.'s long-term prospects.

Key Dates

Keywords

AtriCure Inc, Macquarie Group Limited, Beneficial Ownership, Schedule 13G, Institutional Investment, Common Shares, Medical Devices